New Strong Buy Stocks for January 31st
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
ADMA Biologics, Inc. ADMA: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.
ADMA Biologics Inc Price and Consensus
ADMA Biologics Inc price-consensus-chart | ADMA Biologics Inc Quote
Inhibikase Therapeutics, Inc. IKT: This clinical-stage pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 16% over the last 60 days.
Inhibikase Therapeutics, Inc. Price and Consensus
Inhibikase Therapeutics, Inc. price-consensus-chart | Inhibikase Therapeutics, Inc. Quote
YPF Sociedad Anónima YPF: This international energy company engaging in the integrated business of hydrocarbons has seen the Zacks Consensus Estimate for its current year earnings increasing 24.2% over the last 60 days.
YPF Sociedad Anonima Price and Consensus
YPF Sociedad Anonima price-consensus-chart | YPF Sociedad Anonima Quote
Anavex Life Sciences Corp. AVXL: This clinical stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 7% over the last 60 days.
Anavex Life Sciences Corp. Price and Consensus
Anavex Life Sciences Corp. price-consensus-chart | Anavex Life Sciences Corp. Quote
Ekso Bionics Holdings, Inc. EKSO: This exoskeleton products company has seen the Zacks Consensus Estimate for its current year earnings increasing 25.6% over the last 60 days.
Ekso Bionics Holdings, Inc. Price and Consensus
Ekso Bionics Holdings, Inc. price-consensus-chart | Ekso Bionics Holdings, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
YPF Sociedad Anonima (YPF) : Free Stock Analysis Report
ADMA Biologics Inc (ADMA) : Free Stock Analysis Report
Ekso Bionics Holdings, Inc. (EKSO) : Free Stock Analysis Report
Anavex Life Sciences Corp. (AVXL) : Free Stock Analysis Report
Inhibikase Therapeutics, Inc. (IKT) : Free Stock Analysis Report
